CELEBREX: THE FIRST SPECIFIC INHIBITOR OF COX-2: NEW DATA

Lignende værker

• CELEBREX-A SPECIFIC INHIBITOR OF CYCLOOXIGENASE-2: EFFICACY AND TOLERABILITY
  af: - -
  Udgivet: (2000-04-01)
• What's all the fuss? Safety concerns about COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex)
  af: Wooltorton, Eric
  Udgivet: (2002)
• A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study
  af: Rogers Elaine S, et al.
  Udgivet: (2011-11-01)
• A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study
  af: Rogers, Elaine S, et al.
  Udgivet: (2011)
• Celebrex in treatment of joint diseases in patients with risk factors of gastropathy and cardiovascular palhalodydevelopment
  af: N. V. Chichasova, et al.
  Udgivet: (2004-02-01)